Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study

BACKGROUND: Cytoreductive surgery followed by systemic chemotherapy is the standard of treatment in advanced ovarian cancer where feasible. Neoadjuvant chemotherapy (NACT) followed by surgery is applicable where upfront cytoreductive surgery is not feasible because of few certain reasons. Neverthele...

Descripción completa

Detalles Bibliográficos
Autores principales: Miralpeix, Ester, Sole-Sedeno, Josep-Maria, Rodriguez-Cosmen, Cristina, Taus, Alvaro, Muns, Maria-Dolors, Fabregó, Berta, Mancebo, Gemma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864603/
https://www.ncbi.nlm.nih.gov/pubmed/35197061
http://dx.doi.org/10.1186/s12957-022-02517-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864603/
https://www.ncbi.nlm.nih.gov/pubmed/35197061
http://dx.doi.org/10.1186/s12957-022-02517-1

Ejemplares similares